Investigating the Impact of First-Line Anti-Tuberculosis Drugs Encapsulated in a Eugenol-Based Nanoemulsion on Human Serum Albumin

Parvathy Mohan Menon, Natarajan Chandrasekaran, George Priya Doss C

PDF(5544 KB)
For Authors|For Editors|For Reviewers
PDF(5544 KB)
Discovery Medicine ›› 2024, Vol. 36 ›› Issue (183) : 739-752. DOI: 10.24976/Discov.Med.202436183.70
Article

Investigating the Impact of First-Line Anti-Tuberculosis Drugs Encapsulated in a Eugenol-Based Nanoemulsion on Human Serum Albumin

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2024, 36(183): 739-752 https://doi.org/10.24976/Discov.Med.202436183.70

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(5544 KB)

Accesses

Citation

Detail
Sections
Recommended
Follow Us on
Copyright © 2024.
By using this website, you agree to our Terms & Conditions and Privacy Policy.  
  • Disclaimer
    The statements, opinions and data contained in Discovery Medicine are solely those of the individual authors and contributors and not of the journal and the editor(s). Discovery Medicine stays neutral with regard to jurisdictional claims in published maps and insitutional affiliations.

    • /

    〈 〉